Mid-Year Report
THE MCMANUS GROUP for ALLERGAN INC
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Opposition to repeal of non-interference provision in H.R. 4/S. 3, "Medicare Prescription Drug Price Negotiation Act of 2007" Clarification of scope of Medicaid rebates for physician-administered drugs in Deficit Reduction Act of 2005 (P.L. 109-171).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | N/A |
Health Issues HCR
H.R. 1038, "Access to Life-Saving Medicine Act." S. 1695, "Biologics Price Competition and Innovation Act of 2007" H.R. 2900/S. 1082, Prescription Drug User Fee Act reauthorization
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.